-
Product Insights
Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H2, 2018" provides an overview of Cerebral Infarction (Brain Infarction) clinical trials scenario. This report provides top line data relating to the clinical trials on Cerebral Infarction (Brain Infarction). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Cerebral Vasospasm Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Cerebral Vasospasm Global Clinical Trials Review, H2, 2018" provides an overview of Cerebral Vasospasm clinical trials scenario. This report provides top line data relating to the clinical trials on Cerebral Vasospasm. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2018" provides an overview of Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by...
-
Sector Analysis
Cardiomyopathies Epidemiology Analysis and Forecast, 2021-2031
In the 7MM, the diagnosed prevalent cases of cardiomyopathies was 2,268,240 cases in 2021. The market is expected to grow at an AGR of more than 2% during the forecast period. Cardiomyopathy is a general term for a collection of diverse conditions of the heart muscle that inhibit the heart muscle’s ability to pump blood. The main forms of cardiomyopathy are dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), restrictive cardiomyopathy (RCM), and arrhythmogenic right ventricular cardiomyopathy (ARCM), which combined are referred...
-
Sector Analysis
Arteriosclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
The Arteriosclerosis clinical trial market research report provides an overview of the Arteriosclerosis clinical trials scenario. This report provides top-line data relating to the clinical trials on Arteriosclerosis. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report also offers coverage of disease clinical trials by region, country, phase, trial status, end points status, and sponsor type. The report also provides prominent drugs for in-progress trials.
-
Product Insights
Systolic Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Systolic Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Systolic Heart Failure pipeline landscape. The report provides comprehensive information on the therapeutics under development for Systolic Heart Failure, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news...
-
Sector Analysis
Vasculitis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Vasculitis may occur with multiple symptoms including inflammation, fever, fatigue, weight loss, a rapid pulse, and aches and pains. Also, the damaged blood vessels affect different organs and tissues, leading to various organ disfunction-related symptoms. Vasculitis diagnosis includes imaging and physiological test. The Vasculitis pipeline drugs market report includes an assessment of the disease epidemiology, leading marketed products, and late-to-mid-stage pipeline products with Phase Transition Success Rate (PTSR) and Likelihood of Approval (LoA) for vasculitis. The report also analyzes vasculitis's...
-
Product Insights
Stable Angina Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Stable Angina Global Clinical Trials Review, H2, 2018" provides an overview of Stable Angina clinical trials scenario. This report provides top line data relating to the clinical trials on Stable Angina. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Subarachnoid Hemorrhage Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Subarachnoid Hemorrhage Global Clinical Trials Review, H2, 2018" provides an overview of Subarachnoid Hemorrhage clinical trials scenario. This report provides top line data relating to the clinical trials on Subarachnoid Hemorrhage. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Supraventricular Tachycardia Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Supraventricular Tachycardia Global Clinical Trials Review, H2, 2018" provides an overview of Supraventricular Tachycardia clinical trials scenario. This report provides top line data relating to the clinical trials on Supraventricular Tachycardia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.